Highmark Inc. health insurance overturned its medical policy and now covers the Acessa Procedure, also known as Laparoscopic Radiofrequency Ablation for Fibroids
February 11, 2018 – Dover, Delaware – Acessa Health Inc., developer of the Acessa System® and Dedicated Women ObGyn are excited to announce they completed the first Acessa Procedures for uterine fibroids using the latest Acessa ProVu technology in Delaware. In addition to first procedures in Delaware, Acessa Health Inc. is also proud to announce the medical policy decision by Highmark Inc., one of the largest insurance carriers in Delaware, Pennsylvania and West Virginia, to cover the procedure.
The Acessa Procedure, also known as laparoscopic radiofrequency ablation (RFA) for fibroids, is a minimally invasive procedure to treat uterine fibroids. Studies have shown over 70% of women have uterine fibroids(1). Uterine fibroids cause abnormal heavy menstruation, pelvic pain and bulk symptoms. Hysterectomy prevails as the primary surgical treatment in the United States, even though studies show women increasingly desire less invasive options. The Acessa Procedure revolutionizes the standard of care for fibroids. The Acessa Procedure treats almost all sizes and locations of fibroids –including those outside the uterine cavity and within uterine walls. The procedure requires no cutting or suturing of uterine tissue, and patients typically go home the same day, experiencing minimal discomfort and a rapid return to normal activities.(2)
Dedicated to Women ObGyn is one of the largest OBYN groups in the North East with 17 providers and is nationally recognized for their Collaborative Care Approach. Dr. Laura Moylan and Dr. Robert Hartmann are the two physicians offering the Acessa Procedure for patients with surgeries being performed locally at the Delaware Surgery Center.
Dr. Laura Moylan and Dr. Robert Hartmann recently completed Acessa procedures marking the first in Delaware. Both patients had successful outcomes and are already seeing positive symptom relief.
“We are excited to bring this offering to women in the Delaware region,” said Dr. Moylan, who is a board certified OBGYN. “The Acessa System allows us to treat nearly all fibroids in nearly all locations. Before, when a patient came to us with symptomatic fibroids, I could offer her a myomectomy or hysterectomy, or I could refer them to a radiologist for uterine artery embolization (UAE). As a clinician, I would prefer to offer a less invasive option as a first line surgical treatment. Now, with the Acessa Procedure, I can offer them an outpatient, same day procedure that is proven to solve their fibroid symptoms. It is a game changer.”
“The technology is outstanding and aligns with our mission,” said Dr. Hartmann who has served patients in Dover for over 20 years. The Acessa ProVu system integrates radiofrequency ablation, laparoscopic ultrasound and guidance mapping. “Dedicated to Women’s mission is to provide exceptional, progressive women’s health care in a compassionate environment. With the Acessa Procedure, we are compounding our ability to provide exceptional care for women with fibroids.”
To schedule a consultation to evaluate if you have fibroids and if the Acessa Procedure is an appropriate treatment option, contact Dedicated to Women ObGyn at 302-674-0223.
Highmark Inc, with over 4.6 million members across Delaware, Pennsylvania, West Virginia overturned its policy and now covers the procedure. Highmark’s Medical Policy team conducted a third-party independent review of the technology, outcomes and clinical studies which resulted in overwhelming evidence that the Acessa system is safe, effective, and proven. This decision comes at a pivotal moment where women across the nation are seeking minimally invasive alternatives to hysterectomy.
About Acessa Health Inc. Acessa Health is a women’s health innovator dedicated to advancing minimally invasive, uterine-sparing solutions for women with symptomatic fibroids. The company introduced the use of radiofrequency ablation for the treatment of uterine fibroids and is continuing to develop technologies that improve the lives of its patients. Acessa Health’s headquarters are in Austin, Texas. For more information, visit AcessaProcedure.com.
Yelena Havryliuk, MD, Robert Setton, MD, John Carlow, EdD, MPH, Barry D. Shaktman, MD, Management of Symptomatic Fibroids: Review and Meta-Analysis of the Literature (2006 -2016), Journal of the Society of Laparoendoscopic Surgeons, Vol. 21 (3) Jul-Sept 2017
Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107. doi: 10.1067/mob.2003.99.
Acessa Health, Inc. Kim Rodriguez, 877-412-3828 firstname.lastname@example.org